Literature DB >> 8767503

[Therapeutic alternatives in the treatment of class T1N0 squamous cell carcinoma of the penis: indications and limitations].

L Piva1, N Nicolai, A Di Palo, A Milani, M Merson, R Salvioni, S Stagni, D Vecchio, F Zanoni, S Ferri, G Pizzocaro.   

Abstract

At INT of Milan between 1964 and 1990, 204 consecutive native patients suffering from penile cancer have been treated. 101 (59%) patients out of 171 with invasive cancer (23 affected with Tis were excluded) have been classified T1N0M0. 74 patients have been treated with penis conserving methods, such as circumcision, radiotherapy, laser excision and primary chemotherapy + conserving surgery. Overall local failure and/or nodal relapses occurred in 27% (20/74). Relapses are significantly related with grading but there isn't any relationship with macroscopical aspect or size of the tumor. The conservative treatment had been possible in 80% of patients. In our experience T1N0 clinical stage conservative therapy does not worsen the prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8767503

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  5 in total

1.  Interstitial brachytherapy in carcinoma of the penis.

Authors:  A J Chaudhary; S Ghosh; R L Bhalavat; J N Kulkarni; B V Sequeira
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

2.  [Focal therapy for penile cancer].

Authors:  O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

3.  Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Authors:  Gennaro Musi; Andrea Russo; Andrea Conti; Francesco A Mistretta; Ettore Di Trapani; Stefano Luzzago; Roberto Bianchi; Giuseppe Renne; Stefano Ramoni; Matteo Ferro; Deliu Victor Matei; Marco Cusini; Luca Carmignani; Ottavio de Cobelli
Journal:  World J Urol       Date:  2017-12-02       Impact factor: 4.226

4.  Development and Verification of Prognostic Nomogram for Penile Cancer Based on the SEER Database.

Authors:  Yon-Bo Chen; Ying-Wen Liu; Liang Gao; Liang-You Tang; Jiang Guo; Yu-Chang Tian; Ping-Hong You
Journal:  Biomed Res Int       Date:  2022-04-04       Impact factor: 3.411

Review 5.  Penile sparing therapy for penile cancer.

Authors:  Henry Han-I Yao; Shomik Sengupta; Justin Chee
Journal:  Transl Androl Urol       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.